Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE2

Conditions

Leukemia · Relapse

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

First Affiliated Hospital of Zhejiang University, Hangzhou, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)

Leukemia · Relapsed Leukemia · Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Boston, United States

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia, in Relapse · Acute Myeloid Leukemia Refractory

Abroad (travel likely)Recruiting

Aachen, Germany · Greifswald, Germany

Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia

AML (Acute Myelogenous Leukemia · Relapsed Acute Myelogenous Leukemia · Refractory Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Hangzhou, China

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS

Abroad (travel likely)RecruitingPHASE1

Washington D.C., United States · Baltimore, United States